Skip to main content

Advantages of immunostaining over DNA analysis using PCR amplification to detect p53 abnormality in long-term formalin-fixed tissues of human colorectal carcinomas.

Matsubayashi H, Watanabe H, Nishikura K, Ajioka Y, Maejima T, Kijima H, Saitoh T

Publication: J Gastroenterol (1998) • Vol 33 • Page 662-9PMID: 9773930View on PubMed

Purpose

The purpose of this paper was to determine the effects of duration of formalin fixation on the detection of p53 and Ki-67 through immunohistochemical (IHC) staining and the amplification of p53 and K-ras by PCR using colorectal cancer specimens.

Conclusion

IHC staining of p53 and Ki-67 was observed in tissues fixed in formalin for up to 2 weeks and 1 week, respectively. PCR amplification of p53 and K-ras, using a nested technique, was successful for tissues fixed for up to 1 day and 2 weeks, respectively suggesting IHC detection of p53 is less subjective to over-fixation than PCR amplification of p53.

Studies (2)

Purpose

The purpose of this study was to determine the effects of duration of fixation on the IHC detection of p53 and Ki-67 in colorectal cancer specimens.

Summary of Findings

In 4 specimens found to overexpress p53, the DO7 antibody detected similar amounts of staining in tissues fixed between 1 day and 4 weeks, but tissues fixed for 8 weeks showed decreased staining. A decrease in p53 immunostaining was seen after 4 weeks of fixation using the PAb1801 antibody. Both p53 antibodies showed strong staining after fixation for at least 2 weeks. Ki-67 staining was strong in tissues fixed for 1 day or 1 week but decreased in tissues fixed for 2 weeks or longer.
  • Biospecimens

    TissueColorectal
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationTime in fixative
    1 d
    1 week
    2 weeks
    4 weeks
    8 weeks
    Immunohistochemistry SpecificTargeted peptide/protein
    Ki-67
    p53
    Immunohistochemistry SpecificType of antibody
    DO7
    MIB-1
    PAb1801